EU patent approved for ChemStress®

One of ValitaCell’s key goals is to improve process control for cell based manufacturing systems which is why ChemStress® Fingerprinting was developed. ChemStress® is a novel platform technology which characterises cells using a panel of specific, small molecule chemical stressors. Combining ChemStress® biological relevant outputs with Deep Learning and Artificial Intelligence, we support our customers to achieve the highest levels of bioprocess performance. The EU has recognised the uniqueness of ChemStress® with the approval of a new patent.

The EU patent is: No. 3014268

‘A method of determining or predicting a characteristic of a cell’

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!